Hướng Dẫn Lựa Chọn Người Hiến Tim Ghép: Tổng Quan và Khuyến Nghị

••Khush KK, Potena L, Cherikh WS, Chambers DC, Harhay MO, Hayes Jr D, et al. International Society for Heart and Lung Transplantation. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult heart transplantation report-2020; focus on deceased donor characteristics. J Heart Lung Transplant. 2020;39(10):1003–15. https://doi.org/10.1016/j.healun.2020.07.010. Most recent ISHLT report documenting the international implications of extended donor criteria and guidelines for donor selection. Jasseron C, Legeai C, Jacquelinet C, Nubret-Le Coniat K, Flécher E, Cantrelle C, et al. Optimization of heart allocation: the transplant risk score. Am J Transplant. 2019;19(5):1507–17. https://doi.org/10.1111/ajt.15201. Fudim M, Davis ME, Jenkins C, Brown CL, Wigger MA, Stulak JM, et al. Marginal donor use in patients undergoing heart transplantation with left ventricular assist device explantation. Ann Thorac Surg. 2015;100(6):2117–25. Del Rizzo DF, Menkis AH, Pflugfelder PW, Novick RJ, McKenzie FN, Boyd WD, et al. The role of donor age and ischemic time on survival following orthotopic heart transplantation. J Heart Lung Transplant. 1999;18(4):310–9. https://doi.org/10.1016/s1053-2498(98)00059-x. Samsky MD, Patel CB, Owen A, Schulte PJ, Jentzer J, Rosenberg PB, et al. Ten-year experience with extended criteria cardiac transplantation. Circ Heart Fail. 2013;6(6):1230–8. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000296. Wang Y, Cai J, Sun Y, Zhang J, Xie F, Alshirbini MH, et al. Extended donor criteria in heart transplantation: a retrospective study from a single Chinese institution. J Thorac Dis. 2018;10(4):2153–65. https://doi.org/10.21037/jtd.2018.03.149. Chen JM, Russo MJ, Hammond KM, Mancini DM, Kherani AR, Fal JM, et al. Alternate waiting list strategies for heart transplantation maximize donor organ utilization. Ann Thorac Surg. 2005;80:224–8. Laks H, Marelli D, Fonarow GC, Hamilton MA, Ardehali A, Moriguchi JD, et al. Use of two recipient lists for adults requiring heart transplantation. J Thorac Cardiovasc Surg. 2003;125:49–59. Lima B, Rajagopal K, Petersen RP, Shah AS, Soule B, Felker GM, et al. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. Circulation. 2006;114:I-27–I-32. Patel J, Kobashigawa JA. Cardiac transplantation: the alternate list and expansion of the donor pool. Curr Opin Cardiol. 2004;19:162. Rogers JG, Butler J, Lansman SL, Gass A, Portner PM, Pasque MK, et al. INTrEPID investigators. J Am Coll Cardiol. 2007;50(8):741–7. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435–43. Daneshmand MA, Rajagopal K, Lima B, Khorram N, Blue LJ, Lodge AJ, et al. Left ventricular assist device destination therapy versus extended criteria cardiac transplant. Ann Thorac Surg. 2010;89(4):1205–9; discussion 1210. https://doi.org/10.1016/j.athoracsur.2009.12.058. Singh SSA, Banner NR, Rushton S, Simon AR, Berry C, Al-Attar N. ISHLT Primary graft dysfunction incidence, risk factors, and outcome: a UK national study. Transplantation. 2019;103(2):336–43. Khush KK, Menza R, Nguyen J, Zaroff JG, Goldstein BA. Donor predictors of allograft use and recipient outcomes after heart transplantation. Circ Heart Fail. 2013;6(2):300–9. https://doi.org/10.1161/CIRCHEARTFAILURE.112.000165. Rizzi G, Startseva X, Wolfrum M, Lüscher TF, Ruschitzka F, Fröhlich GM, et al. Unfavorable donor pretransplant APACHE II, SAPS II, and SOFA scores are not associated with outcome: implications for heart transplant donor selection. Transplant Proc. 2016;48(8):2582–7. https://doi.org/10.1016/j.transproceed.2016.06.059. Tryon D, Hasaniya NW, Jabo B, Razzouk AJ, Bailey LL, Rabkin DG. Effect of left ventricular dysfunction on utilization of donor hearts. J Heart Lung Transplant. 2018;37(3):349–57. https://doi.org/10.1016/j.healun.2017.07.015. •Khush KK, Ball RL. Great variability in donor heart acceptance practices across the United States. Am J Transplant. 2020;20(6):1582–96. https://doi.org/10.1111/ajt.15760. A much needed discussion of the current state of donor selection criteria in the US, and a call for greater coordination and collaboration among institutions. Khush KK, Zaroff JG, Nguyen J, Menza R, Goldstein BA. National decline in donor heart utilization with regional variability: 1995–2010. Am J Transplant. 2015;15(3):642–9. https://doi.org/10.1111/ajt.13055. Khush KK. Donor selection in the modern era. Ann Cardiothor Surg. 2018;7:126–34. Hong KN, Iribarne A, Worku B, Takayama H, Gelijns AC, Naka Y, et al. Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient risk factors. Ann Thorac Surg. 2011;92(2):520–7. https://doi.org/10.1016/j.athoracsur.2011.02.086. Smits JM, De Pauw M, de Vries E, Rahmel A, Meiser B, Laufer G, et al. Donor scoring system for heart transplantation and the impact on patient survival. J Heart Lung Transplant. 2012;31(4):387–97. https://doi.org/10.1016/j.healun.2011.11.005. Weiss ES, Allen JG, Kilic A, Russell SD, Baumgartner WA, Conte JV, et al. Development of a quantitative donor risk index to predict short-term mortality in orthotopic heart transplantation. J Heart Lung Transplant. 2012;31(3):266–73. https://doi.org/10.1016/j.healun.2011.10.004. Coutance G, Kransdorf E, Bonnet G, Loupy A, Kobashigawa J, Patel JK. Statistical performance of 16 posttransplant risk scores in a contemporary cohort of heart transplant recipients. Am J Transplant. 2020. https://doi.org/10.1111/ajt.16217. Anyanwu AC, Rogers CA, Murday AJ. A simple approach to risk stratification in adult heart transplantation. Eur J Cardiothorac Surg. 1999;16(4):424–8. https://doi.org/10.1016/s1010-7940(99)00238-9. Segovia J, Cosío MD, Barceló JM, Bueno MG, Pavía PG, Burgos R, et al. RADIAL: a novel primary graft failure risk score in heart transplantation. J Heart Lung Transplant. 2011;30(6):644–51. https://doi.org/10.1016/j.healun.2011.01.721. Foroutan F, Alba AC, Guyatt G, Posada JD, Hing NNF, Arseneau E, et al. Predictors of 1-year mortality in heart transplant recipients: a systematic review and meta-analysis. Heart. 2018;104(2):151–60. https://doi.org/10.1136/heartjnl-2017-311435. Lo BD, Suarez-Pierre A, Zhou X, Lui C, Hunt MF, Whitman GJ, et al. Matchmaking just got easier: Impact of phenotypic donor-recipient likeness in heart transplantation. Ann Thorac Surg. 2020;109(1):102–9. Ansari D, Andersson B, Ohlsson M, Höglund P, Andersson R, Nilsson J. CODUSA—customize optimal donor using simulated annealing in heart transplantation. Sci Rep. 2013;3:1922. https://doi.org/10.1038/srep01922. Nilsson J, Ohlsson M, Höglund P, Ekmehag B, Koul B, Andersson B. The International Heart Transplant Survival Algorithm (IHTSA): a new model to improve organ sharing and survival. PLoS One. 2015;10(3):e0118644. Published 11 Mar 2015. https://doi.org/10.1371/journal.pone.0118644. Murana G, Fiorentino M, Gliozzi G, Di Marco L, Potena L, Martin Suarez S, et al. Donor risk analysis and validation in heart transplants: a single-centre experience. Interact Cardiovasc Thorac Surg. 2020;31(6):860–7. Lietz K, John R, Mancini DM, Edwards NM. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; Implications for donor selection criteria. J Am Coll Cardiol. 2004;43(9):1553–61. https://doi.org/10.1016/j.jacc.2004.02.002. Weber DJ, Wang IW, Gracon AS, Hellman YM, Hormuth DA, Wozniak TC, et al. Impact of donor age on survival after heart transplantation: an analysis of the United Network for Organ Sharing (UNOS) registry. J Card Surg. 2014;29(5):723–8. https://doi.org/10.1111/jocs.12406. Blanche C, Kamlot A, Blanche DA, Kearney B, Magliato KE, Czer LS, et al. Heart transplantation with donors fifty years of age and older. J Thorac Cardiovasc Surg. 2002;123(4):810–5. https://doi.org/10.1067/mtc.2002.120009. Jawitz OK, Raman V, Klapper J, Hartwig M, Patel CB, Milano C. Donor and recipient age matching in heart transplantation: Analysis of the UNOS Registry. Transpl Int. 2019;32(11):1194–202. https://doi.org/10.1111/tri.13481. Bruschi G, Colombo T, Oliva F, Morici N, Botta L, Cannata A, et al. Orthotopic heart transplantation with donors greater than or equal to 60 years of age: a single-center experience. Eur J Cardiothorac Surg. 2011;40(1):e55-61. https://doi.org/10.1016/j.ejcts.2011.02.013. Nagji AS, Hranjec T, Swenson BR, Kern JA, Bergin JD, Jones DR, et al. Donor age is associated with chronic allograft vasculopathy after adult heart transplantation: Implications for donor allocation. Ann Thorac Surg. 2010;90(1):168–75. https://doi.org/10.1016/j.athoracsur.2010.03.043. Meyer SR, Modry DL, Norris CM, Pearson GJ, Bentley MJ, Koshal A, et al. Pretransplant diabetes, not donor age, predicts long-term outcomes in cardiac transplantation. J Card Surg. 2006;21(2):117–24. https://doi.org/10.1111/j.1540-8191.2006.00188.x. Loebe M, Potapov EV, Hummel M, Weng Y, Bocksch W, Hetzer R. Medium-term results of heart transplantation using older donor organs. J Heart Lung Transplant. 2000;19(10):957–63. https://doi.org/10.1016/s1053-2498(00)00178-9. Sorabella RA, Guglielmetti L, Kantor A, Castillero E, Takayama H, Schulze PC, et al. Cardiac donor risk factors predictive of short-term heart transplant recipient mortality: an analysis of the United Network for Organ Sharing Database. Transplant Proc. 2015;47(10):2944–51. https://doi.org/10.1016/j.transproceed.2015.10.021. Lund LH, Edwards LB, Kucheryavaya AY, Dipchand AI, Benden C, Christie JD, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth official adult heart transplant report—2013; focus theme: age. J Heart Lung Transplant. 2013;32(10):951–64. https://doi.org/10.1016/j.healun.2013.08.006. John MM, Shih W, Estevez D, Martens TP, Bailey LL, Razzouk AJ, et al. Interaction between ischemic time and donor age on adult heart transplant outcomes in the modern era. Ann Thorac Surg. 2019;108(3):744–8. https://doi.org/10.1016/j.athoracsur.2019.03.042. Russo MJ, Chen JM, Sorabella RA, Martens TP, Garrido M, Davies RR, et al. The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg. 2007;133(2):554–9. https://doi.org/10.1016/j.jtcvs.2006.09.019. Morgan JA, John R, Weinberg AD, Kherani AR, Colletti NJ, Vigilance DW, et al. Prolonged donor ischemic time does not adversely affect long-term survival in adult patients undergoing cardiac transplantation. J Thorac Cardiovasc Surg. 2003;126:1624–33. Chandola R, Mutsuga M, Norris C, Wang S. Stretching the cardiac donor ischemic time to beyond six hours: what’s the impact? Clin Surg. 2017;2:1578. Shafiq F, Wang Y, Li G, Liu Z, Li F, Zhou Y, et al. Clinical outcome of donor heart with prolonged cold ischemic time: a single-center study. J Card Surg. 2020;35(2):397–404. https://doi.org/10.1111/jocs.14404. Reich HJ, Kobashigawa JA, Aintablian T, Ramzy D, Kittleson MM, Esmailian F. Effects of older donor age and cold ischemic time on long-term outcomes of heart transplantation. Tex Heart Inst J. 2018;45(1):17–22. https://doi.org/10.14503/THIJ-16-6178. Tong CKW, Khush KK. New approaches to donor selection and preparation in heart transplantation. Curr Treat Options Cardiovasc Med. 2021;23(5):28. https://doi.org/10.1007/s11936-021-00906-5. Ardehali A, Esmailian F, Deng M, Soltesz E, Hsich E, Naka Y, et al. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial. Lancet. 2015;385(9987):2577–84. https://doi.org/10.1016/S0140-6736(15)60261-6. Messer S, Page A, Berman M, Colah S, Dunning J, Pavlushkov E, et al. First to 50: Early outcomes following heart transplantation at Royal Papworth Hospital from donation after circulatory determined death (DCD) donors. J Heart Lung Transplant. 2019;38(4):S43. https://doi.org/10.1016/j.healun.2019.01.090. Cernic S, Messer S, Page A, Berman M, Kaul P, Osman M, et al. Donation after circulatory death heart transplantation — the first 5 years a successful leap in activity. J Heart Lung Transplant. 2021;40(4):S140. https://doi.org/10.1016/j.healun.2021.01.433. Chew HC, Iyer A, Connellan M, Scheuer S, Villanueva J, Gao L, et al. Outcomes of donation after circulatory death heart transplantation in Australia. J Am Coll Cardiol. 2019;73(12):1447–59. https://doi.org/10.1016/j.jacc.2018.12.067. Chan JL, Kobashigawa JA, Reich HJ, Ramzy D, Thottam MM, Yu Z, et al. Intermediate outcomes with ex-vivo allograft perfusion for heart transplantation. J Heart Lung Transplant. 2017;36(3):258–63. https://doi.org/10.1016/j.healun.2016.08.015. Sáez DG, Zych B, Sabashnikov A, Bowles CT, De Robertis F, Mohite PN, et al. Evaluation of the organ care system in heart transplantation with an adverse donor/recipient profile. Ann Thorac Surg. 2014;98(6):2099–105. https://doi.org/10.1016/j.athoracsur.2014.06.098. (Epub 2014 Oct 23). Schroder JN, D’Alessandro D, Esmailian F, Boeve T, Tang P, Liao K, et al. Successful utilization of extended criteria donor (ECD) hearts for transplantation — results of the OCSTM Heart EXPAND trial to evaluate the effectiveness and safety of the OCS heart system to preserve and assess ECD hearts for transplantation. J Heart Lung Transplant. 2019;38(4):S42. https://doi.org/10.1016/j.healun.2019.01.088. Weiss ES, Allen JG, Patel ND, Russell SD, Baumgartner WA, Shah AS, et al. The impact of donor-recipient sex matching on survival after orthotopic heart transplantation: analysis of 18 000 transplants in the modern era. Circ Heart Fail. 2009;2(5):401–8. https://doi.org/10.1161/CIRCHEARTFAILURE.108.844183. Bergenfeldt H, Stehlik J, Höglund P, Andersson B, Nilsson J. Donor-recipient size matching and mortality in heart transplantation: Influence of body mass index and gender. J Heart Lung Transplant. 2017;36(9):940–7. https://doi.org/10.1016/j.healun.2017.02.002. Hsich EM, Blackstone EH, Thuita L, McNamara DM, Rogers JG, Ishwaran H, et al. Sex differences in mortality based on united network for organ sharing status while awaiting heart transplantation. Circ Heart Fail. 2017;10:e003635. Litviňuková M, Talavera-López C, Maatz H, Reichart D, Worth CL, Lindberg EL, et al. Cells of the adult human heart. Nature. 2020;588(7838):466–72. https://doi.org/10.1038/s41586-020-2797-4. Izquierdo MT, Almenar L, Martínez-Dolz L, Moro J, Agüero J, Sánchez-Lázaro I, et al. Analysis of the impact of donor gender on early mortality. Transplant Proc. 2007;39:2375–6. Ayesta A, Urrútia G, Madrid E, Vernooij RWM, Vicent L, Martínez-Sellés M. Sex-mismatch influence on survival after heart transplantation: a systematic review and meta-analysis of observational studies. Clin Transplant. 2019;33(12): e13737. https://doi.org/10.1111/ctr.13737. Reed RM, Netzer G, Hunsicker L, Mitchell BD, Rajagopal K, Scharf S, et al. Cardiac size and sex-matching in heart transplantation: Size matters in matters of sex and the heart. JACC Heart Fail. 2014;2(1):73–83. https://doi.org/10.1016/j.jchf.2013.09.005. Melk A, Babitsch B, Borchert-Mörlins B, Claas F, Dipchand AI, Eifert S, et al. Equally interchangeable? How sex and gender affect transplantation. Transplantation. 2019;103(6):1094–110. https://doi.org/10.1097/TP.0000000000002655. Costanzo A, Dipchand R, Starling A, Anderson M, Chan S, Desai, et al. The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29:914–56. Doumouras BS, Fan CS, Mueller B, Dipchand AI, Manlhiot C, Stehlik J, et al. The effect of pre-heart transplant body mass index on posttransplant outcomes: an analysis of the ISHLT Registry Data. Clin Transplant. 2019;33(7): e13621. https://doi.org/10.1111/ctr.13621. Patel ND, Weiss ES, Nwakanma LU, Russell SD, Baumgartner WA, Shah AS, et al. Impact of donor-to-recipient weight ratio on survival after heart transplantation: Analysis of the United Network for Organ Sharing Database. Circulation. 2008;118(14 Suppl):S83–8. https://doi.org/10.1161/CIRCULATIONAHA.107.756866. Chan BB, Fleischer KJ, Bergin JD, Peyton VC, Flanagan TL, Kern JA, et al. Weight is not an accurate criterion for adult cardiac transplant size matching. Ann Thorac Surg. 1991;52(6):1230–5; discussion 1235–6. https://doi.org/10.1016/0003-4975(91)90006-c. Kransdorf EP, Kittleson MM, Benck LR, Patel JK, Chung JS, Esmailian F, et al. Predicted heart mass is the optimal metric for size match in heart transplantation. J Heart Lung Transplant. 2019;38(2):156–65. https://doi.org/10.1016/j.healun.2018.09.017. Khush KK, Cherikh WS, Chambers DC, Harhay MO, Hayes D, Hsich E, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult heart transplantation report — 2019; focus theme: Donor and recipient size match. J Heart Lung Transplant. 2019;38:1056–66. https://doi.org/10.1016/j.healun.2019.08.004. Shudo Y, Cohen JE, Lingala B, He H, Woo YJ. Impact of donor obesity on outcomes after orthotopic heart transplantation. J Am Heart Assoc. 2018;7(23): e010253. https://doi.org/10.1161/JAHA.118.010253. Hussain Z, Yu M, Wozniak A, Kim D, Krepostman N, Liebo M, et al. Impact of donor smoking history on post heart transplant outcomes: a propensity-matched analysis of ISHLT registry. Clin Transplant. 2021;35(1):e14127. Vieira JL, Cherikh WS, Lindblad K, Stehlik J, Mehra MR. Cocaine use in organ donors and long-term outcome after heart transplantation: an International Society for Heart and Lung Transplantation registry analysis. J Heart Lung Transplant. 2020;39(12):1341–50. https://doi.org/10.1016/j.healun.2020.08.018. Brieke A, Krishnamani R, Rocha MJ, Li W, Patten RD, Konstam MA, et al. Influence of donor cocaine use on outcome after cardiac transplantation: Analysis of the United Network for Organ Sharing Thoracic Registry. J Heart Lung Transplant. 2008;27(12):1350–2. https://doi.org/10.1016/j.healun.2008.08.008. Chen CW, Sprys MH, Gaffey AC, Chung JJ, Margulies KB, Acker MA, et al. Low ejection fraction in donor hearts is not directly associated with increased recipient mortality. J Heart Lung Transplant. 2017;36(6):611–5. https://doi.org/10.1016/j.healun.2017.02.001. Oras J, Doueh R, Norberg E, Redfors B, Omerovic E, Dellgren G. Left ventricular dysfunction in potential heart donors and its influence on recipient outcomes. J Thorac Cardiovasc Surg. 2020;159(4):1333-1341.e6. https://doi.org/10.1016/j.jtcvs.2019.06.070. Madan S, Saeed O, Vlismas P, Katsa I, Patel SR, Shin JJ, et al. Outcomes after transplantation of donor hearts with improving left ventricular systolic dysfunction. J Am Coll Cardiol. 2017;70(10):1248–58. https://doi.org/10.1016/j.jacc.2017.07.728. Mohamedali B, Bhat G, Zelinger A. Frequency and pattern of left ventricular dysfunction in potential heart donors: Implications regarding use of dysfunctional hearts for successful transplantation. J Am Coll Cardiol. 2012;60:235–6. Sibona A, Khush KK, Oyoyo UE, Martens TP, Hasaniya NW, Razzouk AJ, et al. Long-term transplant outcomes of donor hearts with left ventricular dysfunction. J Thorac Cardiovasc Surg. 2019;157(5):1865–75. https://doi.org/10.1016/j.jtcvs.2018.07.115. Zaroff JG, Babcock WD, Shiboski SC. The impact of left ventricular dysfunction on cardiac donor transplant rates. J Heart Lung Transplant. 2003;22(3):334–7. https://doi.org/10.1016/s1053-2498(02)00554-5. Venkateswaran RV, Townend JN, Wilson IC, Mascaro JG, Bonser RS, Steeds RP. Echocardiography in the potential heart donor. Transplantation. 2010;89(7):894–901. https://doi.org/10.1097/TP.0b013e3181cfe8e9. Khush KK, Nguyen J, Goldstein BA, McGlothlin DP, Zaroff JG. Reliability of transthoracic echocardiogram interpretation in potential adult heart transplant donors. J Heart Lung Transplant. 2015;34(2):266–9. https://doi.org/10.1016/j.healun.2014.09.046. Borbely XI, Krishnamoorthy V, Modi S, Rowhani-Rahbar A, Gibbons E, Souter MJ, et al. Temporal changes in left ventricular systolic function and use of echocardiography in adult heart donors. Neurocrit Care. 2015;23(1):66–71. https://doi.org/10.1007/s12028-014-0101-x. Goland S, Czer LS, Kass RM, Siegel RJ, Mirocha J, De Robertis MA, et al. Use of cardiac allografts with mild and moderate left ventricular hypertrophy can be safely used in heart transplantation to expand the donor pool. J Am Coll Cardiol. 2008;51(12):1214–20. https://doi.org/10.1016/j.jacc.2007.11.052. Kuppahally SS, Valantine HA, Weisshaar D, Parekh H, Hung YY, Haddad F, et al. Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness. Am J Transplant. 2007;7(10):2388–95. https://doi.org/10.1111/j.1600-6143.2007.01930.x. Marelli D, Laks H, Fazio D, Moore S, Moriguchi J, Kobashigawa J. The use of donor hearts with left ventricular hypertrophy. J Heart Lung Transplant. 2000;19(5):496–503. https://doi.org/10.1016/s1053-2498(00)00076-0. Angermann CE, Spes CH, Willems S, Dominiak P, Kemkes BM, Theisen K. Regression of left ventricular hypertrophy in hypertensive heart transplant recipients treated with enalapril, furosemide, and verapamil. Circulation. 1991;84(2):583–93. https://doi.org/10.1161/01.cir.84.2.583. Grant SC, Rahman AN, Brooks NH. Regression of left ventricular hypertrophy in a transplanted heart. Br Heart J. 1992;68:55–7. Taghavi S, Jayarajan SN, Wilson LM, Komaroff E, Testani JM, Mangi AA. Cardiac transplantation can be safely performed using selected diabetic donors. J Thorac Cardiovasc Surg. 2013;146(2):442–7. https://doi.org/10.1016/j.jtcvs.2013.02.047. Joseph JT, Mulvihill MS, Yerokun BA, Bell SM, Milano CA, Hartwig MG. Elevated donor hemoglobin A1c does not impair early survival in cardiac transplant recipients. Clin Transplant. 2017;31(7). https://doi.org/10.1111/ctr.12995. Stehlik J, Feldman DS, Brown RN, VanBakel AB, Russel SD, Ewald GA, et al. Interactions among donor characteristics influence post-transplant survival: a multi-institutional analysis. J Heart Lung Transplant. 2010;29(3):291–8. https://doi.org/10.1016/j.healun.2009.08.007. Vecchiati A, Tellatin S, Angelini A, Iliceto S, Tona F. Coronary microvasculopathy in heart transplantation: Consequences and therapeutic implications. World J Transplant. 2014;4(2):93–101. https://doi.org/10.5500/wjt.v4.i2.93. Moayedi Y, Gulamhusein AF, Ross HJ, Teuteberg JJ, Khush KK. Accepting hepatitis C virus-infected donor hearts for transplantation: Multistep consent, unrealized opportunity, and the Stanford experience. Clin Transplant. 2018;32(7): e13308. https://doi.org/10.1111/ctr.13308. Doulamis IP, Tzani A, Moustakidis S, Kampaktsis PN, Briasoulis A. Effect of hepatitis C donor status on heart transplantation outcomes in the United States. Clin Transplant. 2021;35(4): e14220. https://doi.org/10.1111/ctr.14220. Organ Procurement and Transplantation Network. Unexpected HCV donor-derived transmissions on the rise. 2019. https://optn.transplant.hrsa.gov/news/unexpected-hcv-donor-derived-transmissions-on-the-rise/. Accessed 23 Jun 2021. Levitsky J, Formica RN, Bloom RD, Charlton M, Curry M, Friedewald J, et al. The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation. Am J Transplant. 2017;17(11):2790–802. https://doi.org/10.1111/ajt.14381. Morris KL, Adlam JP, Padanilam M, Patel A, Garcia-Cortes R, Chaudhry SP, et al. Hepatitis C donor viremic cardiac transplantation: a practical approach. Clin Transplant. 2020;34(1): e13764. https://doi.org/10.1111/ctr.13764. Reyentovich A, Gidea CG, Smith D, Lonze B, Kon Z, Fargnoli A, et al. Outcomes of the treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donors. Clin Transplant. 2020;34(9): e13989. https://doi.org/10.1111/ctr.13989. Schlendorf KH, Zalawadiya S, Shah AS, Wigger M, Chung CY, Smith S, et al. Early outcomes using hepatitis C-positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies. J Heart Lung Transplant. 2018;37(6):763–9. https://doi.org/10.1016/j.healun.2018.01.1293. Kilic A, Hickey G, Mathier M, Sultan I, Gleason TG, Horn E, et al. Outcomes of adult heart transplantation using hepatitis C-positive donors. J Am Heart Assoc. 2020;9(2): e014495. https://doi.org/10.1161/JAHA.119.014495. Chen YC, Chuang MK, Chou NK, Chi NH, Wu IH, Chen YS, et al. Twenty-four year single-center experience of hepatitis B virus infection in heart transplantation. Transplant Proc. 2012;44(4):910–2. https://doi.org/10.1016/j.transproceed.2012.03.040. Dhillon GS, Levitt J, Mallidi H, Valentine VG, Gupta MR, Sista R, et al. Impact of hepatitis B core antibody positive donors in lung and heart-lung transplantation: an analysis of the United Network For Organ Sharing Database. Transplantation. 2009;88(6):842–6. https://doi.org/10.1097/TP.0b013e3181b4e1fd. Manickam P, Krishnamoorthi R, Kanaan Z, Gunasekaran PK, Cappell MS. Prognostic implications of recipient or donor hepatitis B seropositivity in thoracic transplantation: Analysis of 426 hepatitis B surface antigen-positive recipients. Transpl Infect Dis. 2014;16(4):597–604. https://doi.org/10.1111/tid.12256. Urban M, Booth K, Jungschleger J, Netuka I, Schueler S, MacGowan G. Impact of donor variables on heart transplantation outcomes in mechanically bridged versus standard recipients. Interact Cardiovasc Thorac Surg. 2019;28(3):455–64. https://doi.org/10.1093/icvts/ivy262. Morris AA, Vega JD. True, true, and possibly unrelated: Variability in donor heart acceptance practices across the United States. Am J Transplant. 2020;20(6):1477–9. https://doi.org/10.1111/ajt.15855. Kilic A, Weiss ES, Allen JG, George TJ, Yuh DD, Shah AS, et al. Should orthotopic heart transplantation using marginal donors be limited to higher volume centers? Ann Thorac Surg. 2012;94(3):695–702. https://doi.org/10.1016/j.athoracsur.2012.03.069. Arnaoutakis GJ, George TJ, Allen JG, Russell SD, Shah AS, Conte JV, et al. Institutional volume and the effect of recipient risk on short-term mortality after orthotopic heart transplant. J Thorac Cardiovasc Surg. 2012;143(1):157–67, 167.e1. https://doi.org/10.1016/j.jtcvs.2011.09.040.